Preclinical Characterization of NGM936, a Novel Bispecific T Cell Engager Targeting ILT3 for the Treatment of Acute Myeloid Leukemia with Monocytic Differentiation

Autor: Lin, Vicky Y *, Iyer, Anjushree *, Akama, Keith *, Cheng, Rujin *, Yang, Hong *, Aguayo, Jonathan *, Li, Betty *, Kutach, Alan K *, Tang, Jie *, Kaplan, Daniel *, Roda, Julie M *
Zdroj: In Blood 15 November 2022 140 Supplement 1:9063-9064
Databáze: ScienceDirect